O
MRK icon

OppenheimerFunds’s Merck MRK Stock Holding History

OppenheimerFunds’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$745M Sell
9,385,083
-150,143
-2% -$11.2M 0.93% 12
2018
Q4 		$695M Sell
9,535,226
-205,193
-2% -$14.5M 0.99% 13
2018
Q3 		$659M Buy
9,740,419
+66,991
+0.7% +$4.27M 0.77% 19
2018
Q2 		$560M Buy
9,673,428
+1,028,373
+12% +$58M 0.67% 25
2018
Q1 		$449M Sell
8,645,055
-2,961,378
-26% -$160M 0.56% 38
2017
Q4 		$623M Buy
11,606,433
+68,001
+0.6% +$3.77M 0.75% 17
2017
Q3 		$705M Buy
11,538,432
+421,531
+4% +$25.6M 0.87% 13
2017
Q2 		$680M Buy
11,116,901
+939,882
+9% +$57.2M 0.84% 11
2017
Q1 		$617M Buy
10,177,019
+1,192,107
+13% +$72.3M 0.75% 14
2016
Q4 		$505M Buy
8,984,912
+1,139,559
+15% +$66.7M 0.64% 20
2016
Q3 		$467M Buy
7,845,353
+86,158
+1% +$5.04M 0.59% 30
2016
Q2 		$427M Buy
7,759,195
+847,631
+12% +$45.1M 0.56% 37
2016
Q1 		$349M Sell
6,911,564
-140,207
-2% -$6.87M 0.46% 54
2015
Q4 		$355M Sell
7,051,771
-2,370,104
-25% -$119M 0.45% 53
2015
Q3 		$444M Sell
9,421,875
-557,032
-6% -$29.6M 0.6% 32
2015
Q2 		$542M Buy
9,978,907
+4,292,949
+76% +$241M 0.62% 27
2015
Q1 		$312M Sell
5,685,958
-60,151
-1% -$3.41M 0.35% 76
2014
Q4 		$311M Buy
5,746,109
+608,061
+12% +$33.9M 0.35% 81
2014
Q3 		$291M Buy
5,138,048
+1,057,723
+26% +$59.4M 0.32% 82
2014
Q2 		$225M Buy
4,080,325
+123,046
+3% +$6.71M 0.25% 108
2014
Q1 		$214M Buy
3,957,279
+352,919
+10% +$18.3M 0.25% 107
2013
Q4 		$172M Buy
3,604,360
+767,958
+27% +$35.1M 0.21% 135
2013
Q3 		$129M Sell
2,836,402
-203,699
-7% -$9.3M 0.17% 153
2013
Q2 		$135M Buy
+3,040,101
New +$136M 0.19% 138

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

OppenheimerFunds's MRK Position: Q1 2019 in Review

OppenheimerFunds reduced its Merck (MRK) stake by 1.6% in Q1 2019, selling an estimated $11.2M and leaving 9,385,083 shares worth $745M. The position accounts for 0.93% of the portfolio, ranked #12.

OppenheimerFunds first reported a position in MRK in Q2 2013 and has held it in 24 quarters since. 2,292 funds tracked by Wall St. Rank hold MRK as of Q1 2019.

  • OppenheimerFunds held 9,385,083 shares of Merck worth $745M as of Q1 2019.
  • OppenheimerFunds sold 150,143 Merck shares in Q1 2019, an estimated $11.2M.
  • Merck made up 0.93% of OppenheimerFunds's portfolio in Q1 2019, its #12 holding.
  • OppenheimerFunds first reported a position in Merck in Q2 2013 and has held it in 24 quarters since.
  • 2,292 funds tracked by Wall St. Rank held Merck as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.